Hopp til hovedinnhold

Polyfarmasi hos eldre

Sist revidert:
Sist revidert av:


  1. Rochon PA. Drug prescribing for older adults. UpToDate, last updated Feb 19, 2019. UpToDate  
  2. Williams CM. Using medications appropriately in older adults. Am Fam Physician 2002; 66: 1917-24. PubMed  
  3. Cho S, Lau SW, Tandon V, et al. Geriatric drug evaluation: where are we now and where should we be in the future? Arch Intern Med 2011; 171:937. PubMed  
  4. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet 2007; 370:173. PubMed  
  5. Rørvik FB, Laake K. Medisinering hos pensjonærer i alders- og sykehjem. Tidsskr Nor Lægeforen 1990; 110: 1335-8. PubMed  
  6. Kragh A. Två av tre på äldreboenden behandlas med minst tio läkemedel. Kartläggning av läkemedelsförskrivningen i nordöstra Skåne. Läkartidningen 2004; 101: 994-9.
  7. Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16: 110-7. PubMed  
  8. Bootman JL, Harrison DL, Cox E. The health care cost of drug-related morbidity and mortality in nursing facilities. Arch Intern Med 1997; 157: 2089-96. PubMed  
  9. Spigset O. Bruk av legemidler hos eldre. Utposten, nr. 4, 2003.
  10. Ruths S, Straand J. Eldre og legemidler. Oslo: Norsk legemiddelhåndbok, 31.12.2015. legemiddelhandboka.no  
  11. Schoofs MWCJ, van der Klift M, Hofman A et al. Thiazide diuretics and the risk for hip fracture. Ann Intern Med 2003; 139: 476-82. Annals of Internal Medicine  
  12. Alldred DP, Raynor DK, Hughes C, et al. Interventions to optimise prescribing for older people in care homes. Cochrane Database Syst Rev 2013; 2:CD009095. Cochrane (DOI)  
  13. Fried TR, O'Leary J, Towle V, et al. Health outcomes associated with polypharmacy in community-dwelling older adults: a systematic review. J Am Geriatr Soc 2014; 62:2261. PubMed  
  14. Beers MH. Explicit criteria for determining potentially inappropriate medication use by the elderly. An update. Arch Intern Med 1997; 157: 1531-6. PubMed  
  15. Reikvam Å, Madsen S, Landmark K. Antitrombotisk profylakse etter hjerteinfarkt - acetylsalisylsyre, warfarin eller begge? Tidsskr Nor Lægeforen 2003; 123: 1838-40. Tidsskrift for Den norske legeforening  
  16. Krumholz HM, Radford MJ, Wang Y, Chen J, Heiat A, Marciniak TA. National use and effectiveness of beta-blockers for the treatment of elderly patients after acute myocardial infarction. JAMA 1998; 280: 623-9. Journal of the American Medical Association  
  17. Freemantle N, Cleland J, Young P, Mason J, Harrison J. Beta blockade after myocardial infarction: systemic review and meta regression analysis. BMJ 1999; 318: 1730-7. British Medical Journal  
  18. Musini VM, Tejani AM, Bassett K, et al. Pharmacotherapy for hypertension in adults 60 years or older. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD000028. DOI: 10.1002/14651858.CD000028.pub3. DOI  
  19. Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systemic overview of data from individual patients. Lancet 2000; 355; 1575-81.
  20. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med 1999; 341: 709-17. New England Journal of Medicine  
  21. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-97. Journal of the American Medical Association  
  22. Aguilar MI, Hart R. Oral anticoagulants for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2005, Issue 3. Art. No.: CD001927. DOI: 10.1002/14651858.CD001927.pub2. DOI  
  23. Aguilar MI, Hart R. Antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no previous history of stroke or transient ischemic attacks. Cochrane Database of Systematic Reviews 2005, Issue 4. Art. No.: CD001925. DOI: 10.1002/14651858.CD001925.pub2. DOI  
  • Olav Spigset overlege, professor, dr.med., Avdeling for legemidler, St. Olavs Hospital